Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial

Andrew W Gardner, Donald E Parker, Polly S Montgomery, Steve M Blevins, Andrew W Gardner, Donald E Parker, Polly S Montgomery, Steve M Blevins

Abstract

Background: This prospective, randomized, controlled clinical trial compared changes in primary outcome measures of claudication onset time (COT) and peak walking time (PWT), and secondary outcomes of submaximal exercise performance, daily ambulatory activity, vascular function, inflammation, and calf muscle hemoglobin oxygen saturation (StO2) in patients with symptomatic peripheral artery disease (PAD) following new exercise training using a step watch (NEXT Step) home-exercise program, a supervised exercise program, and an attention-control group.

Methods and results: One hundred eighty patients were randomized. The NEXT Step program and the supervised exercise program consisted of intermittent walking to mild-to-moderate claudication pain for 12 weeks, whereas the controls performed light resistance training. Change scores for COT (P<0.001), PWT (P<0.001), 6-minute walk distance (P=0.028), daily average cadence (P=0.011), time to minimum calf muscle StO2 during exercise (P=0.025), large-artery elasticity index (LAEI) (P=0.012), and high-sensitivity C-reactive protein (hsCRP) (P=0.041) were significantly different among the 3 groups. Both the NEXT Step home program and the supervised exercise program demonstrated a significant increase from baseline in COT, PWT, 6-minute walk distance, daily average cadence, and time to minimum calf StO2. Only the NEXT Step home group had improvements from baseline in LAEI, and hsCRP (P<0.05).

Conclusions: NEXT Step home exercise utilizing minimal staff supervision has low attrition, high adherence, and is efficacious in improving COT and PWT, as well as secondary outcomes of submaximal exercise performance, daily ambulatory activity, vascular function, inflammation, and calf muscle StO2 in symptomatic patients with PAD.

Clinical trial registration url: ClinicalTrials.gov. Unique Identifier: NCT00618670.

Keywords: claudication; exercise; peripheral vascular disease.

© 2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.

Figures

Figure 1.
Figure 1.
Consolidated standards of reporting trials (CONSORT) flow diagram of patients through the trial. ITT indicates intent‐to‐treat.

References

    1. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ, Mensah GA, Criqui MH. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013; 382:1329-1340.
    1. Hirsch AT, Hartman L, Town RJ, Virnig BA. National health care costs of peripheral arterial disease in the Medicare population. Vasc Med. 2008; 13:209-215.
    1. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992; 326:381-386.
    1. Gardner AW, Skinner JS, Cantwell BW, Smith LK. Progressive vs single‐stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc. 1991; 23:402-408.
    1. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, Chan C, Celic L, Pearce WH, Schneider JR, Sharma L, Clark E, Gibson D, Martin GJ. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001; 286:1599-1606.
    1. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain: a meta‐analysis. JAMA. 1995; 274:975-980.
    1. Gardner AW, Parker DE, Montgomery PS, Scott KJ, Blevins SM. Efficacy of quantified home‐based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation. 2011; 123:491-498.
    1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter‐society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007; 45suppl S:S5-S67.
    1. Hiatt WR, Marshall JA, Baxter J, Sandoval R, Hildebrandt W, Kahn LR, Hamman RF. Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. J Clin Epidemiol. 1990; 43:597-606.
    1. Gardner AW. Reliability of transcutaneous oximeter electrode heating power during exercise in patients with intermittent claudication. Angiology. 1997; 48:229-235.
    1. Feinberg RL, Gregory RT, Wheeler JR, Snyder SO, Jr, Gayle RG, Parent FN, III, Patterson RB. The ischemic window: a method for the objective quantitation of the training effect in exercise therapy for intermittent claudication. J Vasc Surg. 1992; 16:244-250.
    1. Gardner AW, Parker DE, Webb N, Montgomery PS, Scott KJ, Blevins SM. Calf muscle hemoglobin oxygen saturation characteristics and exercise performance in patients with intermittent claudication. J Vasc Surg. 2008; 48:644-649.
    1. Womack CJ, Sieminski DJ, Katzel LI, Yataco A, Gardner AW. Improved walking economy in patients with peripheral arterial occlusive disease. Med Sci Sports Exerc. 1997; 29:1286-1290.
    1. Montgomery PS, Gardner AW. The clinical utility of a six‐minute walk test in peripheral arterial occlusive disease patients. J Am Geriatr Soc. 1998; 46:706-711.
    1. Gardner AW, Montgomery PS, Scott KJ, Afaq A, Blevins SM. Patterns of ambulatory activity in subjects with and without intermittent claudication. J Vasc Surg. 2007; 46:1208-1214.
    1. Regensteiner JG, Steiner JF, Panzer RL, Hiatt WR. Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease. J Vasc Med Biol. 1990; 2:142-152.
    1. Ware JE., Jr The status of health assessment 1994. Annu Rev Public Health. 1995; 16:327-354.
    1. Gardner AW, Montgomery PS, Blevins SM, Parker DE. Gender and ethnic differences in arterial compliance in patients with intermittent claudication. J Vasc Surg. 2010; 51:610-615.
    1. Hiatt WR, Creager MA, Amato A, Brass EP. Effect of propionyl‐l‐carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery disease. J Cardiopulm Rehabil Prev. 2011; 31:125-132.
    1. McDermott MM, Liu K, Guralnik JM, Criqui MH, Spring B, Tian L, Domanchuk K, Ferrucci L, Lloyd‐Jones D, Kibbe M, Tao H, Zhao L, Liao Y, Rejeski WJ. Home‐based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA. 2013; 310:57-65.
    1. Gardner AW, Skinner JS, Smith LK. Effects of handrail support on claudication and hemodynamic responses to single‐stage and progressive treadmill protocols in peripheral vascular occlusive disease. Am J Cardiol. 1991; 68:99-105.
    1. Tew G, Nawaz S, Zwierska I, Saxton JM. Limb‐specific and cross‐transfer effects of arm‐crank exercise training in patients with symptomatic peripheral arterial disease. Clin Sci (Lond). 2009; 117:405-413.
    1. Brendle DC, Joseph LJ, Corretti MC, Gardner AW, Katzel LI. Effects of exercise rehabilitation on endothelial reactivity in older patients with peripheral arterial disease. Am J Cardiol. 2001; 87:324-329.
    1. Gardner AW, Parker DE, Montgomery PS, Blevins SM, Teague AM, Casanegra AI. Monitored daily ambulatory activity, inflammation, and oxidative stress in patients with claudication. Angiology. 2013; 65:491-496.
    1. McDermott MM, Ferrucci L, Liu K, Criqui MH, Greenland P, Green D, Guralnik JM, Ridker PM, Taylor LM, Rifai N, Tian L, Zheng J, Pearce WH, Schneider JR, Vonesh E. D‐dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease. J Am Geriatr Soc. 2005; 53:1688-1696.
    1. Januszek R, Mika P, Konik A, Petriczek T, Nowobilski R, Nizankowski R. The effect of treadmill training on endothelial function and walking abilities in patients with peripheral arterial disease. J Cardiol. 2014; 64:145-151.
    1. Nowak WN, Mika P, Nowobilski R, Kusinska K, Bukowska‐Strakova K, Nizankowski R, Jozkowicz A, Szczeklik A, Dulak J. Exercise training in intermittent claudication: effects on antioxidant genes, inflammatory mediators and proangiogenic progenitor cells. Thromb Haemost. 2012; 108:824-831.
    1. Saetre T, Enoksen E, Lyberg T, Stranden E, Jorgensen JJ, Sundhagen JO, Hisdal J. Supervised exercise training reduces plasma levels of the endothelial inflammatory markers E‐selectin and ICAM‐I in patients with peripheral arterial disease. Angiology. 2011; 62:301-305.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa